News

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...
Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...
With dementia diagnoses climbing to 55 million cases globally and 10 million new patients identified each year, medical ...
Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...
NHS GP, Dr Amir Khan has shared important advice regarding hearing loss, explaining how keeping on top the ailment can help ...
A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...
Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
Two new studies have provided further insights into the complex links between head injury in elite rugby and potential ...
A different 2021 study found that treating the eye conditions increasing a person’s risk of dementia could actually reverse ...
Dementia rates vary dramatically across U.S. regions in ways that can't be explained by age, education, or health conditions.